Description

Peptide bioregulator (Ala-Glu-Asp / AED)

Cartalax is a peptide-based complex explored for its role in maintaining cartilage integrity, supporting joint flexibility, and aiding in the regeneration of connective tissues. May influence gene expression involved in collagen production and chondrocyte activity. Targets molecular pathways central to the strength and durability of connective tissues. Also potentially reduces inflammation, improving range of motion, and supporting joint recovery after wear or injury.

  1. Caputi S, et al. Effect of short peptides on neuronal differentiation of stem cells. Int J Immunopathol Pharmacol. 2019;33:2058738419828613. PMID: 30791821 | DOI: 10.1177/2058738419828613
  2. Lin’kova NS, et al. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bull Exp Biol Med. 2016;161(1):175-178. PMID: 27259496 | DOI: 10.1007/s10517-016-3370-x
  3. Khavinson V, Linkova N, Diatlova A, Trofimova S. Peptide Regulation of Cell Differentiation. Stem Cell Rev Rep. 2020;16(1):118-125. PMID: 31808038 | DOI: 10.1007/s12015-019-09938-8

Note: Literature is sparse and indexed under the AED (alanyl-glutamyl-aspartic acid) tripeptide concept.

Certificate of Analysis

Laboratory finding: Quantity 24.54 mg against a 20 mg label; report flags +22.7%. Original laboratory report for Cartalax. Product and labeled strength matched. Vial lot/current-stock association has not been confirmed. Refer to the original report for laboratory findings.

Verify this batch

Print or download (PDF)

Serial: COA-1001261-B8VS · Integrity verified